R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Reuters Pharma USA – Lung-I Cheng

Cell and gene therapies continue to be hot topics in the pharma world this year, and some companies are responding to the new treatment modalities with new business units.

R&D

Treating haemophilia with gene therapy is a powerful option,...

Gene therapy has emerged as a novel approach in treating haemophilia.

R&D

Long-acting injectables for biologics: Current landscape an...

Biologics are incredibly powerful and targeted.

R&D

Inside the new world of healthcare data

These days, real-world data collection is in vogue and not hard to come by in healthcare research.

R&D

How predictive safety can help patients

Adverse events due to drug consumption can damage the physical and mental wellbeing of patients and are a huge economic burden for the healthcare system (Sultana et al., 2013).

R&D

Restoring sensitivity to targeted therapies

In this new episode of the mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Steven Powell, CEO of Ribonexus, a new company put together to develop and ultimately commercialis